LAKE LAKELAND INDUSTRIES INC
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 798081 · Fiscal year ends 01/31
Financial factors as of 2026-07-31 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.3%
TTM net income YoY-24.3%
TTM EPS YoY1.4%
Revenue 3-yr CAGR17.0%
Net income 3-yr CAGR—
Margins
Gross margin32.6%
Operating margin-4.1%
Net margin-14.0%
FCF margin-0.3%
EBITDA margin-2.5%
Returns
ROE-19.6%
ROA-12.3%
ROIC (approx.)-4.7%
Asset turnover0.88x
Leverage & solvency
Liabilities / assets39.4%
Debt / equity0.23x
Current ratio2.98x
Interest coverage-3.50x
Cash quality & payout
Operating cash flow / net income0.03x
Accruals ratio-12.0%
Payout ratio—
Capex / revenue-0.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-01-31 | FY20252025-01-31 | FY20252024-04-30 | FY20242024-01-31 | FY20242023-04-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $192.65M | $167.21M | $6.30M | $124.69M | $6.00M |
| Cost of revenue | $129.32M | $98.54M | — | $73.50M | — |
| Gross profit | $63.33M | $68.67M | — | $51.19M | — |
| Operating income | -$15.51M | -$9.27M | — | $5.99M | — |
| Interest expense | $2.15M | $1.65M | — | $52,000 | — |
| Pretax income | -$17.70M | -$18.36M | — | $9.36M | — |
| Income tax | $7.61M | -$281,000 | — | $3.93M | — |
| Net income | -$25.31M | -$18.07M | — | $5.42M | — |
| EBITDA | -$12.71M | -$6.67M | — | $7.89M | — |
| EPS (basic) | -2.63 | -2.43 | — | 0.74 | — |
| EPS (diluted) | -2.63 | -2.43 | — | 0.72 | — |
| Weighted avg. shares (diluted) | 9.63M | 7.43M | — | 7.54M | — |
| Balance sheet | |||||
| Cash & equivalents | $12.52M | $17.48M | $28.36M | $25.22M | $26.02M |
| Short-term investments | — | — | — | $2.16M | — |
| Receivables | $32.04M | $27.61M | $21.76M | $19.20M | $16.86M |
| Inventory | $82.54M | $82.74M | $56.06M | $51.25M | $57.90M |
| Current assets | $134.19M | $136.53M | $113.77M | $101.50M | $107.94M |
| PP&E, net | $11.64M | $13.95M | $11.93M | $10.69M | $9.22M |
| Goodwill | $15.29M | $16.24M | $15.21M | $13.67M | $8.47M |
| Intangibles | $31.72M | $25.50M | $7.92M | $6.83M | $5.94M |
| Total assets | $209.93M | $212.53M | $171.52M | $153.75M | $145.09M |
| Current liabilities | $37.96M | $34.91M | $21.10M | $18.35M | $20.53M |
| Short-term debt | $1.89M | $939,000 | $0 | $298,000 | $115,000 |
| Long-term debt | $30.38M | $16.43M | — | — | — |
| Total debt | $32.27M | $17.36M | — | — | — |
| Total liabilities | $80.81M | $65.91M | $46.41M | $30.29M | $24.96M |
| Shareholders' equity | $129.13M | $146.63M | $125.11M | $123.45M | $120.14M |
| Net debt | $19.76M | -$111,000 | — | — | — |
| Shares outstanding | 9.81M | 9.50M | 7.38M | 7.36M | 7.36M |
| Cash flow statement | |||||
| Operating cash flow | -$15.75M | -$15.88M | — | $10.91M | — |
| Capital expenditure | $671,000 | $1.54M | — | $2.07M | — |
| Free cash flow | -$16.42M | -$17.42M | — | $8.84M | — |
| Investing cash flow | -$1.18M | -$47.74M | — | -$5.12M | — |
| Financing cash flow | $12.51M | $56.59M | — | -$3.45M | — |
| Depreciation & amortization | $2.80M | $2.60M | — | $1.90M | — |
| Stock-based compensation | $3.39M | $1.56M | — | $1.36M | — |
| Dividends paid | $1.15M | $887,000 | — | $908,000 | — |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.